Sabra Healthcare REIT Inc (NASDAQ:SBRA) currently has a daily average trading volume of 2.39M but it saw 2609733 shares traded in last market. With a market cap of 4.11B USD, the company’s current market price of $17.27 came rising about 2.01 while comparing to the previous closing price of $16.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.99 and as low as $13.22. In the recent trading on the day, stock has struck highest price mark of $16.73 while lowest mark touched by it was $17.426.
Taking a look at 20-day trading activity of Sabra Healthcare REIT Inc (SBRA) gives us an average price of $17.29, while its current price level is -13.61% below from 52-week high level whereas it is 30.65% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $16.88 while that of 200 days or SMA-200 reads an average of $17.28. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.83% during that period while stretching the period over a month that decreases to 3.04%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.57 which implies that the stock is in neutral territory.
JMP Securities upgraded its recommendation for the stock as a “Mkt Outperform” from “Mkt Perform” on January 07, 2025 while assigning a price target of $20. Mizuho also issued its recommendations for the stock as it downgraded the price target for the stock is $20.
Over the week, SBRA’s stock price is moving -2.15% down while it is 4.10% when we observe its performance for the past one month. Year-to-date it is -0.29% down and over the past year, the stock is showing an upside performance of 21.47%.
The company is expected to be releasing its next quarterly report on 2025-Feb-18, for which analysts forecasted an EPS of 0.17 while estimate for next year EPS is 0.7. In next quarter, company is expected to be making quarterly sales of $182.52M as analysts are expecting the sales for current fiscal year at $736.56M and seeing the company making $774.84M in sales next year. Moreover, analysts are in estimates of $180.23M for current-quarter revenue.
Currently, Sabra Healthcare REIT Inc’s total number of outstanding shares is 237.59M with 1.30% of that held by the insiders while 101.15% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 2.44% and return on equity (ROE) at 4.57%. It has a price to earnings ratio (P/E ratio) of 32.24 while having a 22.23 of forward P/E ratio. Stock’s beta reads 0.85. Stock has a price to book (P/B) ratio of 1.50 while price to sale or P/S ratio amounts to 5.86. Its return on asset (ROA) is 2.37% on average.
